LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.03
(-1.04%)
CNY 18.03
(-1.04%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.88 Billion CNY | -13.43% |
| 2022 | 5 Billion CNY | 27.55% |
| 2021 | 3.92 Billion CNY | 14.95% |
| 2020 | 3.41 Billion CNY | 11.42% |
| 2019 | 3.06 Billion CNY | 15.51% |
| 2018 | 2.65 Billion CNY | 27.24% |
| 2017 | 2.08 Billion CNY | 19.62% |
| 2016 | 1.74 Billion CNY | 30.35% |
| 2015 | 1.33 Billion CNY | 18.55% |
| 2014 | 1.12 Billion CNY | 22.33% |
| 2013 | 922.07 Million CNY | 19.22% |
| 2012 | 773.42 Million CNY | 16.77% |
| 2011 | 662.34 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.1 Billion CNY | -23.69% |
| 2024 Q1 | 1.44 Billion CNY | 8.69% |
| 2024 Q3 | 1.48 Billion CNY | 39.36% |
| 2023 Q2 | 1.34 Billion CNY | -0.01% |
| 2023 FY | 4.33 Billion CNY | -13.43% |
| 2023 Q4 | 1.32 Billion CNY | -3.57% |
| 2023 Q3 | 1.37 Billion CNY | 2.61% |
| 2023 Q1 | 1.34 Billion CNY | -8.92% |
| 2022 Q1 | 1.06 Billion CNY | -0.0% |
| 2022 FY | 5 Billion CNY | 27.55% |
| 2022 Q4 | 1.47 Billion CNY | 12.25% |
| 2022 Q3 | 1.31 Billion CNY | 13.6% |
| 2022 Q2 | 1.15 Billion CNY | 8.79% |
| 2021 Q4 | 1.06 Billion CNY | 3.53% |
| 2021 Q2 | 973.68 Million CNY | 12.92% |
| 2021 Q1 | 862.29 Million CNY | -7.09% |
| 2021 Q3 | 1.02 Billion CNY | 5.43% |
| 2021 FY | 3.92 Billion CNY | 14.95% |
| 2020 Q3 | 891.87 Million CNY | 7.97% |
| 2020 Q1 | 768.72 Million CNY | -9.97% |
| 2020 Q2 | 826.03 Million CNY | 7.46% |
| 2020 FY | 3.41 Billion CNY | 11.42% |
| 2020 Q4 | 928.1 Million CNY | 4.06% |
| 2019 Q3 | 755 Million CNY | -1.8% |
| 2019 Q2 | 768.8 Million CNY | 11.91% |
| 2019 Q1 | 687 Million CNY | -9.77% |
| 2019 FY | 3.06 Billion CNY | 15.51% |
| 2019 Q4 | 853.83 Million CNY | 13.09% |
| 2018 Q3 | 662.14 Million CNY | 6.25% |
| 2018 FY | 2.65 Billion CNY | 27.24% |
| 2018 Q4 | 761.4 Million CNY | 14.99% |
| 2018 Q1 | 606.43 Million CNY | 1.41% |
| 2018 Q2 | 623.19 Million CNY | 2.76% |
| 2017 Q1 | 461.47 Million CNY | -6.76% |
| 2017 FY | 2.08 Billion CNY | 19.62% |
| 2017 Q4 | 597.98 Million CNY | 12.71% |
| 2017 Q3 | 530.53 Million CNY | 7.14% |
| 2017 Q2 | 495.18 Million CNY | 7.31% |
| 2016 Q2 | 420.55 Million CNY | 11.56% |
| 2016 Q4 | 494.9 Million CNY | 9.81% |
| 2016 FY | 1.74 Billion CNY | 30.35% |
| 2016 Q1 | 376.96 Million CNY | -1.55% |
| 2016 Q3 | 450.69 Million CNY | 7.17% |
| 2015 Q4 | 382.89 Million CNY | 11.19% |
| 2015 Q2 | 313.3 Million CNY | 5.6% |
| 2015 Q1 | 296.67 Million CNY | -8.35% |
| 2015 Q3 | 344.37 Million CNY | 9.92% |
| 2015 FY | 1.33 Billion CNY | 18.55% |
| 2014 Q2 | 263.44 Million CNY | 5.59% |
| 2014 Q4 | 323.71 Million CNY | 11.11% |
| 2014 Q3 | 291.34 Million CNY | 10.59% |
| 2014 FY | 1.12 Billion CNY | 22.33% |
| 2014 Q1 | 249.49 Million CNY | 0.0% |
| 2013 FY | 922.07 Million CNY | 19.22% |
| 2012 FY | 773.42 Million CNY | 16.77% |
| 2011 FY | 662.34 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 281.4 Million CNY | -1990.272% |
| Jointown Pharmaceutical Group Co., Ltd | 9.08 Billion CNY | 35.278% |
| Yifeng Pharmacy Chain Co., Ltd. | 6.5 Billion CNY | 9.552% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 2.73 Billion CNY | -114.999% |